Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 63

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 63
---
 fails to retain and motivate its current personnel, its business and future growth prospects
could be harmed.

Furthermore, in order to attract
and retain key personnel and employees, the compensation amounts for NewGenIvf’s executive officers may change significantly after
consummation of the Business Combination, although there are currently no agreements in place relating to any such post Business Combination
compensation arrangements. As a result, NewGenIvf’s expenses associated with the compensation may increase, which may also have
an adverse effect on its results of operations.

NewGenIvf’s Share Incentive
Plan allows NewGenIvf to enhance its ability to attract and retain exceptionally qualified individuals and agents and to encourage them
to acquire a proprietary interest in the company’s growth and performance. Competition for highly skilled personnel and agents is
often intense and NewGenIvf may incur significant costs or may not be successful in attracting, integrating, or retaining qualified personnel
and agents to fulfill NewGenIvf’s current or future needs. NewGenIvf believes that the granting of share-based awards is of significant
importance to NewGenIvf’s ability to attract and retain agents, key personnel and employees, and NewGenIvf will continue to grant
share-based awards in the future. In addition, NewGenIvf may, with the approval of its Compensation Committee and the Board, revise the
terms of, and increase the size of, its share incentive plan, to ensure that it is able to attract and retain agents, key personnel and
employees. On March 31, 2025, NewGenIvf’s Board approved certain amendments to its Share Incentive Plan, including the increase
of the size of the share incentive plan to 20% of the outstanding shares of the Company from time to time. As a result, NewGenIvf’s
expenses associated with share-based compensation may increase, which may have an adverse effect on NewGenIvf’s results of operations.
The amended share incentive plan is available as Exhibit 4.32.

To successfully market and sell its services and products in Asia-Pacific markets, NewGenIvf must address many international business risks with which NewGenIvf has limited experience.

NewGenIvf’s business
is subject to risks in connection with changes in international, national and local economic and market conditions, including the effects
of global financial crises, effects of terrorist acts and war and global pandemics. Such economic changes could negatively impact infertile
couples’ abilities to pay